{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:57:57Z","timestamp":1793408277195,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jcv.2024.105707","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T05:31:11Z","timestamp":1719034271000},"page":"105707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Does the ultrasensitive HBsAg Next assay enhance Hepatitis B diagnosis? An evaluation of analytical performances"],"prefix":"10.1016","volume":"174","author":[{"given":"Joachim","family":"Bourdin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Salmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lascoux-Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Delaugerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-4381","authenticated-orcid":false,"given":"Sarah","family":"Maylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10381","key":"10.1016\/j.jcv.2024.105707_bib0001","first-page":"1039\u201152","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jcv.2024.105707_bib0002","doi-asserted-by":"crossref","first-page":"541\u20116","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u00ab New \u00bb Antigen in leukemia SERA","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMa"},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic Hepatitis B virus infection","volume":"156","author":"Coffin","year":"2019","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.jcv.2024.105707_bib0004","doi-asserted-by":"crossref","first-page":"338","DOI":"10.21037\/atm.2016.09.11","article-title":"Diagnosis of hepatitis B","volume":"4","author":"Song","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.jcv.2024.105707_bib0005","doi-asserted-by":"crossref","first-page":"585\u2011608","DOI":"10.4254\/wjh.v15.i5.585","article-title":"Current and novel modalities for management of chronic hepatitis B infection","volume":"15","author":"Salama","year":"2023","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0006","doi-asserted-by":"crossref","first-page":"e2525","DOI":"10.1002\/rmv.2525","article-title":"Biomarkers of transfusion transmitted occult hepatitis B virus infection: where are we and what next?","volume":"34","author":"Fu","year":"2024","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"10.1016\/j.jcv.2024.105707_bib0007","doi-asserted-by":"crossref","first-page":"846\u201155","DOI":"10.1111\/jvh.13101","article-title":"A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: evidence of a relevant risk of death and evolution from silent to chronic infection","volume":"26","author":"Salpini","year":"2019","journal-title":"J. Viral. Hepat."},{"issue":"4","key":"10.1016\/j.jcv.2024.105707_bib0008","doi-asserted-by":"crossref","first-page":"479\u201187","DOI":"10.3851\/IMP1771","article-title":"De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation","volume":"16","author":"Ueda","year":"2011","journal-title":"Antivir. Ther."},{"issue":"7","key":"10.1016\/j.jcv.2024.105707_bib0009","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/v14071504","article-title":"Occult Hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses."},{"issue":"suppl_8","key":"10.1016\/j.jcv.2024.105707_bib0010","doi-asserted-by":"crossref","first-page":"S778\u201184","DOI":"10.1093\/infdis\/jix178","article-title":"Characteristics, prevention, and management of Hepatitis B virus (HBV) reactivation in HBV-infected patients who require immunosuppressive therapy","volume":"216","author":"Choi","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"3 Pt 2","key":"10.1016\/j.jcv.2024.105707_bib0011","first-page":"403\u201114","article-title":"Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes","volume":"98","author":"Scheiblauer","year":"2010","journal-title":"Vox. Sang."},{"key":"10.1016\/j.jcv.2024.105707_bib0012","doi-asserted-by":"crossref","first-page":"18\u201125","DOI":"10.1016\/j.jcv.2018.05.009","article-title":"An ultra-sensitive Abbott ARCHITECT\u00ae assay for the detection of hepatitis B virus surface antigen (HBsAg)","volume":"105","author":"Lou","year":"2018","journal-title":"J. Clin. Virol. Off. Publ. Pan. Am. Soc. Clin. Virol."},{"key":"10.1016\/j.jcv.2024.105707_bib0013","doi-asserted-by":"crossref","first-page":"39\u201147","DOI":"10.1016\/j.jviromet.2015.11.016","article-title":"The lumipulse G HBsAg-quant assay for screening and quantification of the hepatitis B surface antigen","volume":"228","author":"Yang","year":"2016","journal-title":"J. Virol. Methods"},{"issue":"11","key":"10.1016\/j.jcv.2024.105707_bib0014","doi-asserted-by":"crossref","first-page":"3484\u201191","DOI":"10.1128\/JCM.00726-13","article-title":"Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance","volume":"51","author":"Shinkai","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.jcv.2024.105707_bib0015","first-page":"533\u20118","article-title":"Performance evaluation of an improved HBsAg assay (HBsAg NEXT) for the detection of HBsAg levels","volume":"15","author":"Gupta","year":"2023","journal-title":"J. Lab. Physicians"},{"issue":"3","key":"10.1016\/j.jcv.2024.105707_bib0016","first-page":"E263\u201174","article-title":"Analysis of hepatitis B surface antigen (HBsAg) using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays","volume":"48","author":"Ozeki","year":"2018","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02204-21","article-title":"Detection of the Hepatitis B surface antigen in patients with occult Hepatitis B by use of an assay with enhanced sensitivity","volume":"60","author":"Wong","year":"2022","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.jcv.2024.105707_bib0018","first-page":"1138\u201147","article-title":"Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay","volume":"37","author":"Shinkai","year":"2017","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jcv.2024.105707_bib0019","doi-asserted-by":"crossref","first-page":"41\u20115","DOI":"10.1016\/j.jcv.2019.08.001","article-title":"Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay","volume":"118","author":"Kuhns","year":"2019","journal-title":"J. Clin. Virol. Off. Publ. Pan. Am. Soc. Clin. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0020","doi-asserted-by":"crossref","first-page":"397\u2011408","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jcv.2024.105707_bib0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12985-021-01706-w","article-title":"Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers","volume":"18","author":"Kuhns","year":"2021","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115033","article-title":"Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative\/Confirmatory assays","volume":"97","author":"Sickinger","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jcv.2024.105707_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105378","article-title":"Versatile performance edges of HBsAg Next assay in diagnosis and therapeutic monitoring of HBV infection","volume":"160","author":"Steve","year":"2023","journal-title":"J. Clin. Virol. Off. Publ. Pan. Am. Soc. Clin. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2024.105707_bib0024","first-page":"275\u201184","article-title":"Evaluation of virological microparticle enzyme immunoassay according to the ISO 15189: real-life experience in a university hospital","volume":"62","author":"Lafontaine","year":"2016","journal-title":"Clin. Lab."},{"issue":"12","key":"10.1016\/j.jcv.2024.105707_bib0025","doi-asserted-by":"crossref","first-page":"1711\u20117","DOI":"10.1099\/jmm.0.000838","article-title":"Verification of the Roche cobas\u00ae 6800 PCR 200 \u00b5l and 500 \u00b5l protocols for the quantification of HIV-1 RNA, HBV DNA and HCV RNA and evaluation with COBAS\u00ae Ampliprep\/COBAS\u00ae TaqMan\u00ae assays","volume":"67","author":"Tan","year":"2018","journal-title":"J. Med. Microbiol."},{"issue":"4","key":"10.1016\/j.jcv.2024.105707_bib0026","doi-asserted-by":"crossref","first-page":"676\u201183","DOI":"10.1016\/j.jhep.2012.11.039","article-title":"Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside\/nucleotide analogue therapy: finite treatment duration unlikely","volume":"58","author":"Chevaliez","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jcv.2024.105707_bib0027","doi-asserted-by":"crossref","first-page":"37\u201146","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal Scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"issue":"4","key":"10.1016\/j.jcv.2024.105707_bib0028","doi-asserted-by":"crossref","first-page":"209\u201119","DOI":"10.1038\/nrgastro.2013.216","article-title":"Management of patients with hepatitis B who require immunosuppressive therapy","volume":"11","author":"Hwang","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0029","doi-asserted-by":"crossref","first-page":"180\u20113","DOI":"10.1016\/j.jinf.2011.11.021","article-title":"Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy","volume":"65","author":"Ceccarelli","year":"2012","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.jcv.2024.105707_bib0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12879-017-2672-6","article-title":"Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal","volume":"17","author":"Cerva","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0031","doi-asserted-by":"crossref","first-page":"198\u2011204","DOI":"10.1111\/jvh.12802","article-title":"Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy","volume":"25","author":"Marrone","year":"2018","journal-title":"J. Viral. Hepat."},{"issue":"1","key":"10.1016\/j.jcv.2024.105707_bib0032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12985-019-1154-4","article-title":"Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors","volume":"16","author":"Kuhns","year":"2019","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.jcv.2024.105707_bib0033","doi-asserted-by":"crossref","first-page":"823\u201133","DOI":"10.1002\/hep.27604","article-title":"Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression","volume":"61","author":"Salpini","year":"2015","journal-title":"Hepatol. Baltim. Md."},{"issue":"9","key":"10.1016\/j.jcv.2024.105707_bib0034","doi-asserted-by":"crossref","first-page":"e29109","DOI":"10.1002\/jmv.29109","article-title":"Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance","volume":"95","author":"Suzuki","year":"2023","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0035","doi-asserted-by":"crossref","first-page":"141\u201151","DOI":"10.1016\/0166-0934(86)90045-5","article-title":"Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test","volume":"14","author":"Sansonno","year":"1986","journal-title":"J. Virol. Methods."},{"issue":"3","key":"10.1016\/j.jcv.2024.105707_bib0036","doi-asserted-by":"crossref","first-page":"376\u201184","DOI":"10.1007\/s00535-016-1244-7","article-title":"Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody","volume":"52","author":"Matsumoto","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jcv.2024.105707_bib0037","first-page":"355\u20119","article-title":"Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients","volume":"55","author":"Brown","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jcv.2024.105707_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1063616","article-title":"Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.jcv.2024.105707_bib0039","doi-asserted-by":"crossref","first-page":"109\u201117","DOI":"10.1016\/j.jviromet.2006.02.009","article-title":"Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra","volume":"135","author":"Weber","year":"2006","journal-title":"J. Virol. Methods."},{"issue":"3\u20114","key":"10.1016\/j.jcv.2024.105707_bib0040","first-page":"159\u201162","article-title":"Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays","volume":"50","author":"Moerman","year":"2004","journal-title":"Clin. Lab."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653224000696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653224000696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:06:29Z","timestamp":1732277189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653224000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":40,"alternative-id":["S1386653224000696"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2024.105707","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the ultrasensitive HBsAg Next assay enhance Hepatitis B diagnosis? An evaluation of analytical performances","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2024.105707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105707"}}